Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|October 4, 2005
Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemiaAyalew Tefferi, Shireen Sirhan, Terra L Lasho, et al.
American Journal of Clinical Pathology|October 1, 2016
Laboratory Investigation of Myeloproliferative Neoplasms (MPNs):  Recommendations of the Canadian Mpn GroupLambert Busque, Anna Porwit, Radmila Day, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 5, 2015
Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms GroupShireen Sirhan, Lambert Busque, Lynda Foltz, et al.
Blood Advances|January 7, 2026
MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasmsMarie Ouellet, Angelo Rizzolo, Caroline Venne, et al.
Advances in Therapy|July 11, 2024
Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2Claire N Harrison, Alessandro M Vannucchi, Christian Recher, et al.
Leukemia Research|October 22, 2008
Oligonucleotide array CGH studies in myeloproliferative neoplasms: comparison with JAK2V617F mutational status and conventional chromosome analysisAyalew Tefferi, Shireen Sirhan, Yi Sun, et al.
Annals of Surgical Oncology|December 23, 2023
Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer NetworkJames Tankel, Nabeel Ahmed, Carmen Mueller, et al.
Bone Marrow Transplantation|November 8, 2023
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative studyDawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
Mayo Clinic Proceedings|March 3, 2019
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease SubgroupsNatasha Szuber, Mythri Mudireddy, Maura Nicolosi, et al.
Leukemia|February 6, 2024
Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group StudyJames T England, Natasha Szuber, Shireen Sirhan, et al.
Pageof 3